E09.00 Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)

Name of the Condition

• Drug or Chemical Induced Diabetes Mellitus with Hyperosmolarity Without Nonketotic Hyperglycemic-Hyperosmolar Coma (NKHHC) (ICD-10 Code: E09.00)

Summary

Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC) is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to severe dehydration and increased blood osmolality. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and hyperosmolar states without the presence of coma.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia. Common culprits include medications (e.g., glucocorticoids, diuretics, or antipsychotics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to hyperosmolarity due to fluid loss from osmotic diuresis.

Risk Factors

• Use of medications known to affect glucose metabolism (e.g., steroids, thiazide diuretics).
• Exposure to chemicals or toxins that disrupt endocrine function.
• Pre-existing metabolic conditions that increase susceptibility to drug-induced effects.
• High doses or prolonged use of the causative agent.
• Dehydration or inadequate fluid intake, which exacerbates hyperosmolarity.

Symptoms

• Excessive thirst and frequent urination.
• Dry mouth and skin.
• Fatigue and weakness.
• Confusion or altered mental status (without coma).
• Headache and dizziness.
• Nausea and vomiting.

Diagnosis

Diagnosis involves confirming hyperglycemia and hyperosmolarity through blood tests, including serum glucose and osmolality levels. Urine tests may show glycosuria, and electrolyte imbalances are common. Clinical evaluation assesses for signs of dehydration and rules out other causes of hyperglycemia. The absence of ketosis and coma distinguishes this condition from diabetic ketoacidosis or NKHHC.

Treatment Options

Treatment focuses on correcting hyperglycemia and dehydration. Intravenous fluids are administered to restore fluid balance, and insulin therapy may be used to lower blood sugar levels. Underlying causative agents are identified and discontinued if possible. Electrolyte imbalances are corrected, and ongoing monitoring of blood glucose and osmolality is essential.

Prognosis and Follow-Up

Prognosis depends on timely intervention and the severity of dehydration. With prompt treatment, most patients recover, but delayed care can lead to complications. Follow-up includes regular monitoring of blood glucose, electrolytes, and renal function. Long-term management may involve discontinuing or adjusting the causative medication and addressing any residual metabolic effects.

Complications

• Severe dehydration and electrolyte imbalances.
• Acute kidney injury or failure.
• Neurological changes, including confusion or seizures.
• Increased risk of infection due to hyperglycemia.
• Potential progression to nonketotic hyperglycemic-hyperosmolar coma if untreated.

Lifestyle & Prevention

• Avoid or minimize exposure to medications or chemicals known to affect glucose metabolism.
• Maintain adequate hydration, especially during illness or high-risk situations.
• Monitor blood sugar levels if using glucose-altering medications.
• Follow healthcare provider guidance on medication management and dosage adjustments.

When to Seek Professional Help

Seek immediate medical attention if experiencing symptoms of hyperosmolarity, such as excessive thirst, confusion, or dehydration. Prompt evaluation is critical to prevent progression to coma or organ damage. Contact a healthcare provider if blood sugar levels are persistently high or if new medications are prescribed that may affect glucose regulation.

Tips for Medical Coders

When coding E09.00, ensure documentation specifies the absence of nonketotic hyperglycemic-hyperosmolar coma (NKHHC) to distinguish it from related conditions. Verify that the hyperosmolarity is drug or chemical induced and not due to other causes. Include details about the causative agent, if available, to support the diagnosis. Accurate coding requires clear documentation of hyperglycemia, hyperosmolarity, and the absence of coma.